Comparison of the Permanent Skin Flora of Children Who Had Bathing With Two Different Products
1 other identifier
interventional
60
1 country
1
Brief Summary
This study was carried out as a randomized controlled experimental study to compare the effect of wiping bath with 2% daily chlorhexidine gluconate and soap-free body wash on the permanent skin flora of children hospitalized in the PICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2021
CompletedFirst Submitted
Initial submission to the registry
April 11, 2021
CompletedFirst Posted
Study publicly available on registry
April 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2022
CompletedApril 19, 2021
April 1, 2021
1 year
April 11, 2021
April 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
permanent skin flora
Blood Agar Base will be used to evaluate permanent skin flora
3 days
Study Arms (2)
2% chlorhexidine gluconate
EXPERIMENTAL4% Chlorhexidine gluconate solution and one to one water will be used to create a 2% Chlorhexidine gluconate solution.
soap-free body cleaning solution
ACTIVE COMPARATORIt supports and protects the natural barrier function of the skin's natural protective layer.
Interventions
Children in 2% chlorhexidine gluconate group , which is the routine practice of the hospital, and a wiping bath in accordance with the bath protocol specified. The bath procedure will take 10-15 minutes. Before wiping bath swab sample will provide from armpit and groin with circular manner and 6 hours later swap sample will be provided from the same areas again. The swab sample taken will be planted on blood agar medium and kept at + 4-8 ℃ for an average of 18-24 hours. After it is planted on blood agar medium, it will be kept at + 4-8 ℃ for an average of 18-24 hours . A total of 12 swab samples will be taken for 3 days from each child and from the same areas, body flora will be evaluated.
Children in a wiping bath with soap-free body washing solution group, and a wiping bath in accordance with the bath protocol specified. The bath procedure will take 10-15 minutes. Before wiping bath swab sample will provide from armpit and groin with circular manner and 6 hours later swap sample will be provided from the same areas again. The swab sample taken will be planted on blood agar medium and kept at + 4-8 ℃ for an average of 18-24 hours. After it is planted on blood agar medium, it will be kept at + 4-8 ℃ for an average of 18-24 hours . A total of 12 swab samples will be taken for 3 days from each child and from the same areas, body flora will be evaluated.
Eligibility Criteria
You may qualify if:
- Being in the first 24 hours of admission to the PICU
- Internal reasons for hospitalization with children
- No co-morbid disease
- Hospitalization in PICU during data collection procedure
You may not qualify if:
- Hospitalization just before the study
- The children who is not available for wiping bath
- Hospitalized children after surgical procedures
- Antibotic use during the study
- Being chlorhexidine gluconate allergy history
- Impaired skin integrity (burns, skin disease etc.)
- Use of antibiotics, probiotics or steroid-containing immune system suppressing agents at last two months
- Radiotherapy or the chemotherapy patients
- Severe septic shock
- The children with tracheostomy, PEG, permanent dialysis catheter etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Çağrı Çövener Özçelik
Istanbul, Maltepe, 34854, Turkey (Türkiye)
Related Publications (9)
Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK. Host-bacterial symbiosis in health and disease. Adv Immunol. 2010;107:243-74. doi: 10.1016/B978-0-12-381300-8.00008-3.
PMID: 21034976BACKGROUNDClemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012 Mar 16;148(6):1258-70. doi: 10.1016/j.cell.2012.01.035.
PMID: 22424233BACKGROUNDCostello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009 Dec 18;326(5960):1694-7. doi: 10.1126/science.1177486. Epub 2009 Nov 5.
PMID: 19892944BACKGROUNDElias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005 Aug;125(2):183-200. doi: 10.1111/j.0022-202X.2005.23668.x.
PMID: 16098026BACKGROUNDHuman Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012 Jun 13;486(7402):215-21. doi: 10.1038/nature11209.
PMID: 22699610BACKGROUNDKarki S, Cheng AC. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect. 2012 Oct;82(2):71-84. doi: 10.1016/j.jhin.2012.07.005. Epub 2012 Aug 11.
PMID: 22889522RESULTGrice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011 Apr;9(4):244-53. doi: 10.1038/nrmicro2537.
PMID: 21407241RESULTKong HH, Segre JA. Skin microbiome: looking back to move forward. J Invest Dermatol. 2012 Mar;132(3 Pt 2):933-9. doi: 10.1038/jid.2011.417. Epub 2011 Dec 22.
PMID: 22189793RESULTWhitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6578-83. doi: 10.1073/pnas.95.12.6578.
PMID: 9618454RESULT
MeSH Terms
Interventions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof
Study Record Dates
First Submitted
April 11, 2021
First Posted
April 15, 2021
Study Start
February 15, 2021
Primary Completion
February 15, 2022
Study Completion
February 15, 2022
Last Updated
April 19, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share